Literature DB >> 31081013

Characterization of multiresistance gene cfr(C) variants in Campylobacter from China.

Dejun Liu1,2, Xing Li1, Weiwen Liu1, Hong Yao1, Zhihai Liu1, Andrea T Feßler3, Junjia He1, Yuqing Zhou1, Zhangqi Shen1, Zuowei Wu4, Stefan Schwarz1,3, Qijing Zhang4, Yang Wang1.   

Abstract

OBJECTIVES: To investigate the occurrence, the genetic environment and the functionality of novel variants of the MDR gene cfr(C) in Campylobacter from China.
METHODS: A total of 370 Campylobacter isolates of porcine and chicken origin collected from three regions of China in 2015 were screened for cfr(C) by PCR. The phenotypes and genotypes of cfr(C)-positive isolates were investigated by antimicrobial susceptibility testing, PFGE, MLST, S1-PFGE, Southern blotting and WGS. Quantitative RT-PCR was used to compare the expression levels of the cfr(C) variants in their original isolate and clone constructs in Campylobacter jejuni NCTC 11168.
RESULTS: Four (1.1%) porcine Campylobacter coli isolates were positive for cfr(C). They failed to show elevated MICs of phenicols. The deduced Cfr(C) sequences identified exhibited 2-6 amino acid changes compared with the original Cfr(C) reported in the USA. Cloning of the cfr(C) variant genes into C. jejuni NCTC 11168 resulted in ≥32-fold increases in the MICs of phenicols, indicating that the cfr(C) variant genes are functional. The cfr(C)-carrying isolates belonged to three genotypes and WGS analysis revealed the cfr(C) genes were chromosomally located in MDR genomic islands, which contained multiple antibiotic resistance genes of Gram-positive origin.
CONCLUSIONS: This study identified chromosomal cfr(C) genes in C. coli isolates from China. They appeared functionally dormant in the original isolates but were fully functional when cloned and expressed in C. jejuni. The cfr(C) genes were co-transferred with other antibiotic resistance genes, possibly from Gram-positive bacteria. These findings reveal new insights into the function and transmission of cfr(C) in Campylobacter.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2019        PMID: 31081013     DOI: 10.1093/jac/dkz197

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Antibiotic Resistance in the Alternative Lifestyles of Campylobacter jejuni.

Authors:  Daise Aparecida Rossi; Carolyne Ferreira Dumont; Ana Carolina de Souza Santos; Maria Eduarda de Lourdes Vaz; Renata Resende Prado; Guilherme Paz Monteiro; Camilla Beatriz da Silva Melo; Vassiliki Jaconi Stamoulis; Jandra Pacheco Dos Santos; Roberta Torres de Melo
Journal:  Front Cell Infect Microbiol       Date:  2021-05-13       Impact factor: 5.293

2.  Emergence of fexA in Mediating Resistance to Florfenicols in Campylobacter.

Authors:  Biao Tang; Yizhi Tang; Ling Zhang; Xiao Liu; Jiang Chang; Xiaodong Xia; Hua Yang; Zhangqi Shen
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

3.  Characterization and Prevalence of Campylobacter spp. From Broiler Chicken Rearing Period to the Slaughtering Process in Eastern China.

Authors:  Yuanyue Tang; Qidong Jiang; Haiyan Tang; Zhenyu Wang; Yi Yin; Fangzhe Ren; Linghua Kong; Xinan Jiao; Jinlin Huang
Journal:  Front Vet Sci       Date:  2020-04-30

4.  Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria.

Authors:  Stefan Schwarz; Wanjiang Zhang; Xiang-Dang Du; Henrike Krüger; Andrea T Feßler; Shizhen Ma; Yao Zhu; Congming Wu; Jianzhong Shen; Yang Wang
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

5.  Analysis of combined resistance to oxazolidinones and phenicols among bacteria from dogs fed with raw meat/vegetables and the respective food items.

Authors:  Yifan Wu; Run Fan; Yinchao Wang; Lei Lei; Andrea T Feßler; Zheng Wang; Congming Wu; Stefan Schwarz; Yang Wang
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.